Downregulation of Src enhances the cytotoxic effect of temozolomide through AKT in glioma. [electronic resource]
Producer: 20130912Description: 1395-8 p. digitalISSN:- 1791-2431
- Animals
- Apoptosis -- drug effects
- Brain Neoplasms -- drug therapy
- Cell Line, Tumor
- Dacarbazine -- administration & dosage
- Down-Regulation
- Gene Expression Regulation, Neoplastic -- drug effects
- Glioblastoma -- drug therapy
- Glioma -- drug therapy
- Humans
- Mice
- Oncogene Protein v-akt -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Temozolomide
- Xenograft Model Antitumor Assays
- src-Family Kinases -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.